ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (LENSAR), a global leader in next generation femtosecond
laser technology for refractive cataract surgery, announced the filing
of a Chapter 11 bankruptcy petition on December 19, 2016 to reduce its
debt, strengthen its balance sheet and strengthen its platform for
future growth. The filing was made with support from PDL BioPharma, Inc.
(PDL), LENSARs senior secured lender. LENSAR, which acquired the assets
of LENSAR, LLC, anticipates prompt filing of a plan with support from
PDL that will reduce LENSARs debt, convert a portion of PDLs
outstanding debt into equity, and facilitate PDLs financial support of
LENSAR thro…
Read the full article at: http://www.businesswire.com/news/home/20161219005734/en/LENSAR®-Strategic-Restructure-Partnership-PDL-BioPharma